依达拉奉治疗急性脑梗死的疗效观察

目的探讨依迭拉奉治疗急性脑梗死的疗效。方法将100例急性脑梗死患者随机分为治疗组和对照组，每组各50例，对照组用常规治疗方法，治疗组在常规治疗的基础上加用依达拉奉注射液，进行疗效评定。结果治疗组总有效率（84％）明显优于对照组（64％），神经功能缺损评分改善显著（P〈0．05），治疗组和对照组的起效时间相比，治疗组明显早于对照组，差异有显著性。结论依达拉奉注射液能有效改善急性脑梗死的神经功能缺失和日常生活能力，并能更好地控制脑梗死的进展。

Clinical observation on efficacy of Edaravone in treatment of patients with acute cerebral infarction

Objective To investigate the edaravone treatment of acute cerebral infarction. Methods 100 cases of acute cerebral infarction were randomly divided into treatment group and control group, 50 cases in each group, control group with conventional treatment, the treatment group in the conventional treatment plus edaravone injection for efficacy evaluation. Results The total effective rate （84%） was significantly better than the control group （64%）, neurological deficit scores improve significantly （P 〈0.05, treatment group and control group compared to the onset time, the treatment group was significantly earlier than the control group, there was a significant difference. Conclusion edaravone injection can effectively improve the acute cerebral infarction and neurological deficits in activities of daily living, and better able to control the progress of cerebral infarction.